EU authorizes bovine milk osteopontin as a novel food

"EU authorizes bovine milk osteopontin (bmOPN) as a novel food. The regulation states that: 1. Bovine milk osteopontin is authorized to be placed on the market within the Union and shall be included in the Union list of novel foods. 2. It can be used in infant formula, follow-on formula and in milk-based drinks intended for young children, at levels not exceeding 151 mg/L in the final product. 3. Standard specifications of bovine milk osteopontin like composition, microbial limits, contaminant limits were given. 4. Only the company Arla Foods Ingredients Group P/S is authorized to place the bovine milk osteopontin on the market within the Union, for a period of five years from 26 March 2023, unless a subsequent applicant obtains an authorization for that novel food without reference to the scientific data protected pursuant to Article 3 or with the agreement of Arla Foods Ingredients Group P/S."